Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- The Week In Review: Biopharma News Back In The Forefront
Nov 23, 2008 12:24 PM
- Analyst Comments: Lawson, Hawaiian Electric, Allied Irish Banks, Qualcomm, PMI Group, RAIT Financial, Ford Motor, Johnson & Johnson, Syneron
Jun 17, 2008 01:06 PM
- Israeli Inflation Surges: What Should Investors Do?
May 16, 2008 11:37 AM
- Premarket Report
May 15, 2008 09:40 AM
- Hedge Fund Masters 2008...Everyone Loves Qualcomm
Feb 25, 2008 01:46 PM
- Analyst Comments: Hanger Ortho, Moody's, Brightpoint, DRS Technologies, Alnylam, Net Servicos, Mitsubishi Financial, Alpharma, Aftermarket Tech, Telmex, Cree, CPFL Energia, Kimco Realty, Masco, Fred's, Cousins Properties, BioSphere, Schering-Plough
Feb 14, 2008 01:45 PM
- Analyst Comments: CONSOL Energy, XTO Energy, McGraw-Hill, Cutera, Motorola, Syneron Medical
Jan 22, 2008 05:40 PM
- What is a Long Term Investor to do?
Jan 18, 2008 01:52 AM
- Hedge Fund Masters
Nov 16, 2007 02:36 PM
- NASDAQ Technical Picture - Tipping Point or Anniversary Anxiety
Oct 22, 2007 10:20 AM
- Syneron Medical Announces the Establishment of Syneron China
Nov 19, 2008 06:10 AM
- Syneron Medical Adopts Shareholder Rights Plan
Nov 11, 2008 04:13 PM
- Syneron Reports Third Quarter 2008 Revenues of $28.5 Million
Nov 11, 2008 06:31 AM
- Syneron(TM) Acquires San Diego-Based Inlight Corp.
Nov 04, 2008 04:33 PM
- Syneron Medical to Present at Oppenheimer Healthcare Conference and Barclays Capital Small and Mid-Cap Healthcare Conference
Oct 28, 2008 08:01 AM
- Syneron Issues Preliminary Results for the Third Quarter of 2008 and Schedules Quarterly Earnings Conference Call
Oct 20, 2008 07:30 AM
- Syneron Medical to Present at Maxim Group Growth Conference
Oct 02, 2008 04:40 PM
- Syneron(TM) Receives FDA Clearance for Versatile Matrix RF(TM) Fractional Ablative Applicator
Sep 23, 2008 03:19 PM
- Syneron Receives European CE Mark for Versatile Matrix RF(TM) Fractional Ablative Applicator
Sep 19, 2008 06:02 AM
- Syneron Medical to Present at UBS Global Life Sciences Conference
Sep 18, 2008 09:00 AM
Analyst Ratings
|
|
Share Performance
|
Period
|
ELOS
|
Compare to S&P
|
| YTD |
-48.17 %
|
-0.01 %
|
| 4 Weeks |
-29.21 %
|
-22.55 %
|
| 12 Weeks |
-53.08 %
|
-33.61 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -75.00 %
|
|
EPS Growth in Last Year: -71.43 %
|
|
Sales Growth in Last Quarter: -25.48 %
|
|
Sales Growth in Last Quarter: -13.82 %
|
|
|
